Marburg vaccine shows promising results in first-in-human study: NIH
by Press Release from Outbreak News Today on (#68D76)
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, could someday be an important tool to [...]
The post Marburg vaccine shows promising results in first-in-human study: NIH appeared first on Outbreak News Today.